VCYTVeracyte, Inc.
44.73USD-0.67%Mkt Cap: 3.52B USDP/E: 40.83Last update: 2026-05-26

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for …

Indicators:|

Key Statistics

Company
Market Cap3.52B USD
Enterprise Value3.21B USD
Revenue (TTM)541.74M USD
Gross Profit362.53M USD
Net Income (TTM)66.35M USD
Revenue/Share6.861 USD
Last Price44.73 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees755
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS92337F1075
Valuation
P/E (Trailing)40.83
P/E (Forward)23.72
PEG
EV/EBITDA30.77
EV/Revenue5.92
P/S6.66
P/B2.74
EPS (TTM)1.08
EPS (Forward)1.91
52W Range
22.6179% of range50.71
52W High50.71 USD
52W Low22.61 USD
Profitability
Gross Margin70.10%
Oper. Margin16.28%
EBITDA Margin19.24%
Profit Margin12.83%
ROE5.07%
ROA4.72%
Growth
Revenue Growth21.50%
Earnings Growth288.90%
Cash Flow & Leverage
Operating CF136.31M USD
CapEx (TTM)9.68M USD
FCF Margin19.29%
FCF Yield2.97%
Net Debt-399.73M USD
Net Debt/EBITDA-3.84
Balance Sheet
Debt/Equity0.03
Current Ratio9.30
Quick Ratio8.72
Book Value/Sh16.50 USD
Cash/Share5.503 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)47.40 USD
Target Range37.00 USD55.00 USD
# Analysts10
Ownership
Shares Out.79.79M
Float79.36M
Insiders0.52%
Institutions113.11%
Short Interest
Short Ratio9.3d
Short % Float10.19%
Short % Out.8.61%
Shares Short6.87M
Short (prev mo.)6.33M
Technical
SMA 5034.69 (+28.9%)
SMA 20036.62 (+22.1%)
Beta1.89
S&P 52W Chg28.31%
Avg Vol (30d)974.15K
Avg Vol (10d)1.06M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)